ZebraEye

Almaty · founded 2023
HealthTech & MedTech Open sources

AI diagnostics of rare eye diseases using OCT scans. Founded in 2023 by Yana Ten, Arman Ospanov, and Doszhan Zhusupov; focused on the Chinese market per statement on 16.04.2026.

About

ZebraEye is a Kazakhstani medical AI startup in ophthalmology developing artificial intelligence software for the early diagnosis of rare eye pathologies from optical coherence tomography (OCT) scans. The company was founded in 2023 in Almaty by Yana Ten (CEO), Arman Ospanov, and Doszhan Zhusupov. In an interview with Forbes Kazakhstan on 26.07.2024, the founder reported that total investment in development amounted to approximately $300,000, including personal contributions from the founders (Arman Ospanov, Doszhan Zhusupov, Yana Ten) and funds from private investors (the exact equity breakdown and valuation were not disclosed). According to an interview with Yana Ten published by The Tech on 16.04.2026, the project went through a crisis and was relaunched with a pivot toward the Chinese market in partnership with the Khan Tengri Innovation Hub in Shanghai; earlier plans for CE/FDA certification and current fundraising needs are under editorial review.

Founders

YT
Yana TenCEO
AO
Arman OspanovCo-founder
DZ
Doszhan ZhusupovCo-founder

Team information is compiled from open sources and may be updated by our editors.

RAEM Coverage

Profile history

Profile published in directory
Editorial data verification

Sources

Is this your company?

Verify that you represent ZebraEye to update this profile and receive inquiries from investors and partners.

Similar startups

All in sector →
$300KHealthTech · AlmatyWebsite ↗
REPRESENTATIVE VERIFICATION

Claim company representative access

Verified representatives can update metrics, publish company news to the feed, and receive direct investor inquiries.

✓

Request sent